Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The AMPK pathway in fatty liver disease
Chunqiu Fang, Jianheng Pan, Ning Qu, et al.
Frontiers in Physiology (2022) Vol. 13
Open Access | Times Cited: 180

Showing 1-25 of 180 citing articles:

Glucagon-like peptide-1 receptor: mechanisms and advances in therapy
Zhikai Zheng, Zong Yao, Yiyang Ma, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 88
Autophagy and the unfolded protein response shape the non-alcoholic fatty liver landscape: decoding the labyrinth
Zahra Dashti, Zeynab Yousefi, Pouria Kiani, et al.
Metabolism (2024) Vol. 154, pp. 155811-155811
Closed Access | Times Cited: 18
Alternate‐day fasting enhanced weight loss and metabolic benefits over pair‐fed calorie restriction in obese mice
Hadia Nawaz, Haneul Lee, Sumin Kang, et al.
Obesity (2025)
Closed Access | Times Cited: 2
Liraglutide attenuates type 2 diabetes mellitus-associated non-alcoholic fatty liver disease by activating AMPK/ACC signaling and inhibiting ferroptosis
Tingli Guo, Wenhui Yan, Xin Cui, et al.
Molecular Medicine (2023) Vol. 29, Iss. 1
Open Access | Times Cited: 33
Metabolic-Dysfunction Associated Steatotic Liver Disease -Its Pathophysiology, Association with Atherosclerosis and Cardiovascular Disease, and Ideal Treatments
Hidekatsu Yanai, Hiroki Adachi, Mariko Hakoshima, et al.
(2023)
Open Access | Times Cited: 24
Advances in management of metabolic dysfunction-associated steatotic liver disease: from mechanisms to therapeutics
Yuxiao Jiang, Lili Wu, Xiaopeng Zhu, et al.
Lipids in Health and Disease (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 12
A quantitative weight-of-evidence method for confidence assessment of adverse outcome pathway networks: A case study on chemical-induced liver steatosis
A. Verhoeven, J. van Ertvelde, Joost Boeckmans, et al.
Toxicology (2024) Vol. 505, pp. 153814-153814
Closed Access | Times Cited: 9
Thyme, oregano, and rosemary: herbs and food supplements for the management of metabolic associated fatty liver disease
Hamza Elbouny, Ayoub Amssayef, Rania Benjamaa, et al.
Nutrire (2025) Vol. 50, Iss. 1
Closed Access | Times Cited: 1
AlphaFold-Based AI Docking Reveals AMPK/SIRT1-TFEB Pathway Modulation by Traditional Chinese Medicine in Metabolic-Associated Fatty Liver Disease
Lulu Zhang, Yi Zheng, Mingyan Shao, et al.
Pharmacological Research (2025), pp. 107617-107617
Open Access | Times Cited: 1
The Role of GLP1-RAs in Direct Modulation of Lipid Metabolism in Hepatic Tissue as Determined Using In Vitro Models of NAFLD
Ana G. Petrovic, Dunja Igrec, Karla Rožac, et al.
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 6, pp. 4544-4556
Open Access | Times Cited: 22
Programmed cell death and lipid metabolism of macrophages in NAFLD
Zhun Xiao, Minghao Liu, Fangming Yang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 19
Effect of natural polysaccharides on alcoholic liver disease: A review
Siyu Li, Xin Zhou, Ruhai Chen, et al.
International Journal of Biological Macromolecules (2023) Vol. 251, pp. 126317-126317
Closed Access | Times Cited: 19
Tiaogan Jiejiu Tongluo Formula attenuated alcohol-induced chronic liver injury by regulating lipid metabolism in rats
Chunqiu Fang, Jingzhou Zhang, Jiajun Han, et al.
Journal of Ethnopharmacology (2023) Vol. 317, pp. 116838-116838
Closed Access | Times Cited: 17
Xiaozhi formula attenuates non-alcoholic fatty liver disease by regulating lipid metabolism via activation of AMPK and PPAR pathways
Liping You, Tao Wang, Wenxuan Li, et al.
Journal of Ethnopharmacology (2024) Vol. 329, pp. 118165-118165
Open Access | Times Cited: 7
Polygala fallax Hemsl polysaccharides alleviated alcoholic fatty liver disease by modifying lipid metabolism via AMPK
Rui Lv, Houkang Cao, Mingli Zhong, et al.
International Journal of Biological Macromolecules (2024), pp. 135565-135565
Closed Access | Times Cited: 6
From Kinases to Diseases: Investigating the Role of AMPK in Human Pathologies
Verónica Rey, Isaac Tamargo‐Gómez
Kinases and Phosphatases (2023) Vol. 1, Iss. 3, pp. 181-205
Open Access | Times Cited: 15
Effect of Isoquercitrin on Free Fatty Acid-Induced Lipid Accumulation in HepG2 Cells
Sou Hyun Kim, Chawon Yun, Doyoung Kwon, et al.
Molecules (2023) Vol. 28, Iss. 3, pp. 1476-1476
Open Access | Times Cited: 14
SGLT2 inhibitors and AMPK: The road to cellular housekeeping?
Naser Safaie, Shahab Masoumi, Shaban Alizadeh, et al.
Cell Biochemistry and Function (2024) Vol. 42, Iss. 1
Closed Access | Times Cited: 5
Exploring the Therapeutic Potential of Royal Jelly in Metabolic Disorders and Gastrointestinal Diseases
Hesham R. El‐Seedi, Suzy Munir Salama, Aida A. Abd El‐Wahed, et al.
Nutrients (2024) Vol. 16, Iss. 3, pp. 393-393
Open Access | Times Cited: 5
Berberine Effects in Pre-Fibrotic Stages of Non-Alcoholic Fatty Liver Disease—Clinical and Pre-Clinical Overview and Systematic Review of the Literature
Florentina Ioniţă‐Radu, Cristina Patoni, Andreea Simona Nancoff, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 8, pp. 4201-4201
Open Access | Times Cited: 5
A narrative review on the mechanism of natural flavonoids in improving glucolipid metabolism disorders
Wen-jing Niu, Yongshi Feng, Minwen Peng, et al.
Phytotherapy Research (2024) Vol. 38, Iss. 8, pp. 4202-4229
Closed Access | Times Cited: 5
Fanlian Huazhuo Formula alleviates high-fat diet-induced non-alcoholic fatty liver disease by modulating autophagy and lipid synthesis signaling pathway
Mengyuan Niu, Gengting Dong, Yi Li, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 30, pp. 3584-3608
Closed Access | Times Cited: 5
Activation of AMPK Entails the Protective Effect of Royal Jelly against High-Fat-Diet-Induced Hyperglycemia, Hyperlipidemia, and Non-Alcoholic Fatty Liver Disease in Rats
Alaa Hasanain Felemban, Ghedeir M. Alshammari, Abu ElGasim A. Yagoub, et al.
Nutrients (2023) Vol. 15, Iss. 6, pp. 1471-1471
Open Access | Times Cited: 12
Targeting antioxidant factor Nrf2 by raffinose ameliorates lipid dysmetabolism-induced pyroptosis, inflammation and fibrosis in NAFLD
Jiahe Liu, Yuwei Zheng, Songya Yang, et al.
Phytomedicine (2024) Vol. 130, pp. 155756-155756
Closed Access | Times Cited: 4
Ferulic acid restores mitochondrial dynamics and autophagy via AMPK signaling pathway in a palmitate-induced hepatocyte model of metabolic syndrome
Yitong Li, Weiyang Zhao, Ali Tahir Sair, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top